Hinova Pharmaceuticals Inc. (SHA:688302)
China · Delayed Price · Currency is CNY 40.32
-0.38 (-0.93%)
At close: Mar 30, 2026
Hinova Pharmaceuticals Market Cap
Hinova Pharmaceuticals has a market cap or net worth of 3.99 billion as of March 30, 2026. Its market cap has increased by 21.12% in one year.
Market Cap
3.99B
Enterprise Value
3.18B
Revenue
20.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
40.32
Market Cap Chart
Since April 12, 2022, Hinova Pharmaceuticals's market cap has increased from 2.98B to 3.99B, an increase of 33.95%. That is a compound annual growth rate of 7.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 4.03B | -17.23% |
| Dec 31, 2025 | 4.87B | 60.11% |
| Dec 31, 2024 | 3.04B | -41.02% |
| Dec 29, 2023 | 5.16B | 29.14% |
| Dec 30, 2022 | 3.99B | 33.95% |
| Apr 12, 2022 | 2.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Bioperfectus Technologies | 4.66B |
| Hefei Lifeon Pharmaceutical | 4.58B |
| Shanghai Obio Technology (Group) Corp. | 4.29B |
| Pulike Biological Engineering | 4.28B |
| Guanhao Biotech | 3.97B |
| Zhejiang Wecome Pharmaceutical Company | 3.94B |
| Baolingbao Biology | 3.76B |
| Qingdao Vland Biotech INC. | 3.73B |